CONSOLIDATED SUPPLY AGREEMENTConsolidated Supply Agreement • February 27th, 2015 • Horizon Pharma PLC • Pharmaceutical preparations • New York
THIS CONSOLIDATED SUPPLY AGREEMENT (this “AGREEMENT”), is made effective as of the 31 day of July 2013 (the “EFFECTIVE DATE”) by and between Vidara Therapeutics Research, Ltd. (“VIDARA”), an Irish corporation, having an address at Adelaide Chambers, Peter Street, Dublin 8, Ireland and Boehringer Ingelheim RCV GmbH & Co KG (“BI RCV”), an Austrian limited liability partnership, having its registered office at Dr. Boehringer-Gasse 5 – 11, A-1121 Vienna, Republic of Austria (and successor-in-interest of Boehringer Ingelheim Austria GmbH). VIDARA and BI RCV may be referred to herein each individually as a “Party” and jointly as the “Parties.”
Amendment No. 2 (hereinafter the “Amendment No. 2”) to the Consolidated Supply Agreement effective 31 July 2013, (hereinafter the “AGREEMENT”)Consolidated Supply Agreement • August 8th, 2016 • Horizon Pharma PLC • Pharmaceutical preparations
